{"title":"[Effect of tianlong xifeng granule on gan-yang-hua-feng zheng in cerebral arteriosclerosis].","authors":"Zhen-jia Yi, Wei-guo Xu, Sui-yu Hu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the efficacy of Tianlong Xifeng granule (TXG) in the treatment of ceroarterosclerosis (CAS) with Gan-yang-hua-feng Zheng(GYHFZ).</p><p><strong>Methods: </strong>Patients with CAS were randomly divided into 2 groups: 122 patients in the treatment group were given TXG, while 60 patients in the control group were treated with Ginkgo Biloba capsule. Clinical symptom, blood lipid and transcranial doppler ultrasound were observed before and after the treatment.</p><p><strong>Results: </strong>The symptom, elasticity of the cerebral blood vessel, and the speed of blood flow were significantly improved in the treatment group, and the efficacy of the treatment group was superior to that of the control group. Blood lipid was effectively reduced, and no toxic and side effects were found in both groups.</p><p><strong>Conclusion: </strong>TXG has ideal therapeutic effect on CAS patients with GYHFZ.</p>","PeriodicalId":13115,"journal":{"name":"Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University","volume":"28 4","pages":"401-4"},"PeriodicalIF":0.0000,"publicationDate":"2003-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To investigate the efficacy of Tianlong Xifeng granule (TXG) in the treatment of ceroarterosclerosis (CAS) with Gan-yang-hua-feng Zheng(GYHFZ).
Methods: Patients with CAS were randomly divided into 2 groups: 122 patients in the treatment group were given TXG, while 60 patients in the control group were treated with Ginkgo Biloba capsule. Clinical symptom, blood lipid and transcranial doppler ultrasound were observed before and after the treatment.
Results: The symptom, elasticity of the cerebral blood vessel, and the speed of blood flow were significantly improved in the treatment group, and the efficacy of the treatment group was superior to that of the control group. Blood lipid was effectively reduced, and no toxic and side effects were found in both groups.
Conclusion: TXG has ideal therapeutic effect on CAS patients with GYHFZ.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
